Labry’s fund- the investor. Thomas TJ Silverman
Post# of 36537
Little busy right now but I’ll guess acquisition/merger with Markers “Tappimmune” and the other neo antigen deal with Third Rock’s IPO launched Neon Therapeutics. https://endpts.com/neoantigen-pioneer-neon-th...treatment/
A very full agenda for the conference call!